Advertisment
Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:735

Official publication of the Indian Society of Nephrology
  Search
 
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~Related articles
 ~  Article in PDF (705 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 
   Abstract
  Introduction
  Case Report
  Discussion
   References
   Article Figures

 Article Access Statistics
    Viewed2078    
    Printed77    
    Emailed0    
    PDF Downloaded64    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 


 
  Table of Contents  
CASE REPORT
Year : 2012  |  Volume : 22  |  Issue : 3  |  Page : 221-223
 

Light chain deposition disease in a postrenal transplant patient


1 Department of Histopathology, Renal Transplant Surgery, PGIMER, Chandigarh, India
2 Department of Immunology, Renal Transplant Surgery, PGIMER, Chandigarh, India
3 Department of Nephrology, Renal Transplant Surgery, PGIMER, Chandigarh, India

Date of Web Publication20-Jul-2012

Correspondence Address:
K Joshi
Department of Histopathology, Post graduate Institute of Medical Education and Research, Chandigarh 160 012
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-4065.98768

Rights and Permissions

  Abstract 

The morphological spectrum of light chain deposition disease (LCDD) may range from normal glomerular morphology to mesangio-proliferative to mesangio-capillary to nodular sclerosing patterns. Due to the inconsistencies regarding treatment and the universally poor graft outcome of post-transplant LCDD, it is imperative to maintain a high index of suspicion and perform relevant investigations for clinching this diagnosis. A 40-year-old lady was diagnosed as a case of membrano-proliferative glomerulonephritis 3 years back, for which she underwent a live unrelated renal allograft transplant. Postoperative period was complicated by an acute rise in serum creatinine on the 21 st postoperative day. Biopsy showed patchy acute cortical necrosis, which responded to conservative management. The present admission was for renal failure and subnephrotic proteinuria. A kidney biopsy was performed, and all the 14 glomeruli examined showed a mesangiocapillary pattern of glomerular injury with cellular nodule formation in some. The nodules were PAS and Congo red negative. Immunofluorescence showed glomerular and tubular basement staining for Kappa light chains only. Electron microscopy showed the characteristic granular deposits in subendothelial location in the glomerulus, and in tubular basement membranes, thus confirming the diagnosis of LCDD. Membranoproliferative pattern of glomerular injury in the pre- and posttransplant setting has a wide range of differential diagnoses; LCDD being one of them.


Keywords: Light chain deposition disease, postrenal transplant kidney, glomerulus


How to cite this article:
Mittal N, Bansal R, Nada R, Minz R, Minz M, Joshi K. Light chain deposition disease in a postrenal transplant patient. Indian J Nephrol 2012;22:221-3

How to cite this URL:
Mittal N, Bansal R, Nada R, Minz R, Minz M, Joshi K. Light chain deposition disease in a postrenal transplant patient. Indian J Nephrol [serial online] 2012 [cited 2021 Jan 18];22:221-3. Available from: https://www.indianjnephrol.org/text.asp?2012/22/3/221/98768



  Introduction Top


Pure light chain deposition disease (LCDD) in kidney is classically described by the presence of nodular glomerulosclerosis by light microscopy, monoclonal deposits of light chains within renal basement membranes by immunofluorescence, and electron-dense, granular deposits along basement membranes by electron microscopy. [1] Clinical manifestations may range from nephrotic syndrome (in 30-50% of patients), <1 g/day proteinuria (~25% patients), progressive renal insufficiency (in approximately 70% of patients), and hypertension (in more than 80% of the patients) among others. [2] Morphologically, the accumulation of immunoglobulin light chains in the kidney may involve the glomeruli, tubules, or the interstitium and vessels, exclusively or concurrently, and generate a wide spectrum of pathologic findings that may resemble many diseases, including minimal change disease, diabetic glomerulosclerosis, amyloidosis, membranoproliferative glomerulonephritis type 1, and nonspecific interstitial fibrosis and tubular atrophy. [1],[3],[4],[5] The importance of differentiating these conditions from LCDD cannot be overemphasized. The therapy is different, so is the prognosis and patient survival. Despite the limited data available, LCDD invariably recurs in the graft with poor graft survival. Thus, the more or less universal agreement on discouraging renal transplant in LCDD makes it mandatory for it to be diagnosed in a pretransplant patient with renal failure. The present case exemplifies this fact.


  Case Report Top


Herein we present a case of a 43-year-old lady, non-diabetic, non-hypertensive, who underwent a live unrelated renal allograft 3 years back. Renal biopsy done elsewhere was reported as chronic glomerulonephritis possibly "Mesangiocapillary glomerulonephritis" (glass slides of the pretransplant biopsy could not be retrieved). There was no evidence of any other organ system dysfunction at the time of transplant. On day 21 after transplant, she reported to our hospital for an acute increase in serum creatinine to 3.2 mg/dl from a base line of 1.9 mg/dl. The urine output was reduced with mild proteinuria (<1 g/day). An allograft biopsy was performed which showed infarction of a part of the cortical tissue. Stain for acid fast bacilli and fungi (Grocott's stain) did not show any organisms. The noninfarcted area consisted of eight glomeruli which were unremarkable, so were the tubules, interstitium, and blood vessels. No thrombosed vessels were seen. The glomeruli or blood vessels did not show any changes of thrombotic microangiopathy. There was no evidence of rejection or drug overdose. C4d stain was performed and was negative in the peritubular capillaries. Cyclosporine levels were within normal limits. Renal function improved over a period of 10 days, and at the time of discharge, her serum creatinine was 1.2 mg/dl, urine output was adequate, and there was no proteinuria. She was continued on triple immunosuppression (Tacrolimus, MMF, and prednisolone) and was followed up in the outpatient department for a year which was largely uneventful, following which she was lost to follow-up. Twenty-six months after the transplant, she presented with worsening renal allograft function and diarrhoea. The diarrhea responded to broad-spectrum antibiotics and thus was bacterial in origin. However, the renal function deteriorated rapidly. Her serum creatinine increased from 3.2 to 5.6 mg/dl in a period of 1 week with a proteinuria of 1.5 g/day. Urine microscopy showed 5-10 RBCs per high-power field; no casts or crystals were seen. A renal biopsy was done which had a single linear core with 14 glomeruli. Majority of the glomeruli showed lobular expansion by cellular nodules of varying sizes accompanied by thickening of the glomerular capillary wall. The nodules were composed of endocapillary proliferation and mesangial hypercellularity which was global in some, and focal in rest. Three glomeruli showed only uniform glomerular capillary wall thickening devoid of any proliferation. Overall, the findings were consistent with a "mesangiocapillary pattern of glomerular injury." The nodules were pale on periodic acid Schiff stain and were Congo red negative. Masson's trichrome stain failed to show any fuschinophilic immune complex deposits in the glomerular mesangium and/or capillary walls. Also, the tubular basement membranes (TBMs) of nonatrophic tubules appeared thicker and refractile even in the areas devoid of any tubulointerstitial scarring, and this finding was confirmed on Masson's trichrome stain. Immunohistochemistry was performed for Kappa and Lamba antibodies which showed preferential staining of the TBMs and glomerular capillary walls by Kappa antibodies only. Tissue was submitted only for light microscopy, thus immunofluorescence was done from the paraffin-embedded tissue using the proteinase K digestion method, and EM using the standard protocols for formalin-fixed tissue. Immunofluorescence showed marked staining of the glomerular capillary walls along with TBMs by Kappa antibody. In contrast. Lambda was positive in a few casts only. There was no deposition of any other antisera (IgG, IgA, IgM. and C3) studied. Electron microscopy showed the characteristic dark, granular deposits in the subendothelial location in the glomerulus and focally in the tubular basement membranes, thus confirming the diagnosis of LCDD [Figure 1]. Subsequent investigations revealed a monoclonal "M" spike in both the urine and serum electrophoresis. Serum-free light chain assay was elevated with a markedly elevated Kappa: Lambda ratio. Bone marrow examination showed 15% plasma cells; however, no lytic lesions were seen on the bone scans. On follow-up, patient's renal function deteriorated further, she became oliguric, and had to be started on maintenance hemodialysis.
Figure 1: A panel of photomicrographs of light microscopy (a and b, H and E, x100), immunofluorescence (c, H and E, x50), and electron microscopy (d, H and E, x5000) of the renal biopsy of the index case. (a) A glomerulus showing mesangiocapillary pattern with mesangial hypercellularity and nodule formation (arrow head), focal endocapillary proliferation (bold arrow), and glomerular capillary wall thickening with focal splitting (fine arrow). (b) Another glomerulus showing predominantly capillary wall thickening with only an occasional focus of mesangial hypercellularity (arrow) and no nodularity. (c) Immunoflorescence for Kappa antisera showed marked positivity in the tubular basement membranes. Similar positivity was also seen in the glomerular capillary walls. Lambda antisera was negative in these locations and so were other immunoglobulin antisera (IgG, IgM, and IgA). (d) Ultrastructure photomicrograph showing granular electron-dense deposits along the subendothelial region of the glomerular capillary wall which are diagnostic of MIDD

Click here to view



  Discussion Top


LCDD was first described about three decades ago, [6] and since then, the reported incidence of LCDD is quite low. However, due to varied clinical presentations and many differential diagnoses on morphology; it is possibly both underrecognized and underreported. Advanced renal failure requiring dialysis is a common finding at presentation. [7] The most common pattern on morphology is nodular mesangial sclerosis, which is preceded by other morphological manifestations, including mesangial and membranoproliferative patterns, and even minimal change disease. [4],[5] A high index of suspicion and pretransplant screening of patients for LCDD by serum and urine electrophoresis is the only way to clinch the diagnosis. As the upper limit of age for kidney transplantation has increased, increasing number of patients with monoclonal gammopathy of undertermined significance may be encountered. The importance of pretransplant diagnosis lies in the experience gained in posttransplant patients with LCDD. Only a few patients with LCDD, both diagnosed and undiagnosed pretransplant, have undergone renal transplant. [7],[8],[9] The notion of freedom from the disease and increasing graft survival was behind the idea of kidney transplant in diagnosed cases of LCDD. Although limited to a few studies, the results obtained are universally discouraging. The disease recurs in the allograft in at least 80% of patients with a mean recurrence interval of 5-50 months after transplant. [7],[8] The graft-to-recurrence interval in the index case was 26 months. In one of the largest single-center experience of renal transplantation in patients with LCDD, of seven posttransplant patients, four died after the transplant due to graft complications, two after going on dialysis, and the remaining three died due to complications of the disease with graft still functioning. [9] The median reported survival rates after transplant are 18 months to 5 years, that too, with considerable morbidity. [9] Short, et al. [8] reviewed six of their own cases of LCDD and one case from the case report by David-Neto. [9] The latter case, which is an exception rather than the rule, was the only one with a 44 months recurrence-free period. Several factors predic poorer outcome, including age, initial serum creatinine, serum calcium, types of immunoglobulin deposits, and types of lesions seen on renal biopsy. [1] Overall, given the downhill course of LCDD in posttransplant patients, renal transplant is to be discouraged by all means. Although it cannot be confirmed that the index case is a recurrence of LCDD in the graft kidney rather than a de novo occurrence, however, considering the limited availability of immunofluorescence, and unavailability of electron microscopy in most of the private sector establishments in our country, the proposal is justified. So take-home messages from this case are that the morphological spectrum of LCDD has a wide range of differential diagnosis, resulting in potential under/misdiagnosis. It invariably recurs in the posttransplant period with a high potential of graft failure/death of the patient, hence kidney transplant is to be avoided unless measures (pre- and posttransplant) can be taken to control the production of abnormal light chains.

 
  References Top

1.Lin J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, et al. Renal monoclonal immunoglobulin deposition disease: The disease spectrum. J Am Soc Nephrol 2001;12:1482-92.  Back to cited text no. 1
    
2.Pozzi C, Locatelli F. Kidney and liver involvement in monoclonal light chain disorders. Semin Nephrol 2002;22:319-30.  Back to cited text no. 2
[PUBMED]    
3.Howell DN, Gu X, Herrera GA. Organized deposits in the kidney and look-alikes. Ultrastruct Pathol 2003;27:295-312.  Back to cited text no. 3
[PUBMED]    
4.Strøm EH, Fogazzi GB, Banfi G, Pozzi C, Mihatsch MJ. Light chain deposition disease of the kidney: Morphological aspects in 24 patients. Virchows Arch 1994;425:271-80.  Back to cited text no. 4
    
5.Sanders PW, Herrera GA, Kirk KA, Old CW, Galla JH. Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition. Lab Invest 1991;64:527-37.  Back to cited text no. 5
    
6.Randall RE, Williamson WC Jr, Mullinax F, Tung MY, Still WJ. Manifestations of systemic light chain deposition. Am J Med 1976;60:293-9.  Back to cited text no. 6
    
7.Leung N, Lager DJ, Gertz MA, Wilson K, Kanakiriya S, Fervenza FC. Long-term outcome of renal transplantation in light-chain deposition disease. Am J Kidney Dis 2004;43:147-53.  Back to cited text no. 7
    
8.Short AK, O'Donoghue DJ, Riad HN, Short CD, Roberts IS. Recurrence of light chain nephropathy in a renal allograft. A case report and review of the literature. Am J Nephrol 2001;21:237-40.  Back to cited text no. 8
    
9.David-Neto E, Ianhez LE, Chocair PR, Saldanha LB, Sabbaga E, Arap S. Renal transplantation in systemic light-chain deposition (SLCD): A 44 month follow-up without recurrence. Transplant Proc 1989;21:2128-9.  Back to cited text no. 9
    


    Figures

  [Figure 1]

This article has been cited by
1 Monoclonal gammopathy of renal significance with light-chain deposition disease diagnosed postrenal transplant: a diagnostic and therapeutic challenge
Aruna Nambirajan,Dipankar Bhowmik,Geetika Singh,Sanjay Kumar Agarwal,Amit Kumar Dinda
Transplant International. 2014; : n/a
[Pubmed] | [DOI]



 

Top
Print this article  Email this article
 

    

Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07